Addex Therapeutics Quote - 0QNV

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

3.02

Bid

0.00

Ask

0.00

Volume

0.00

0.00 Day's Range 0.00

3.02 52 Week Range 3.02

Market Cap

556.749M

Previous Close

3.02

Open

Last Trade

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

605

Shares Outstanding

184,354,000

Dividend Yield

PE Ratio

-52.71

Earnings Per Share (EPS)

-0.06

Revenue

1.61M

Net Profit

-10.56M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.addextherapeutics.com

Headquarters

Geneva, Che

Founded

Addex Therapeutics Ltd is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0QNV. The last closing price for Addex Therapeutics was CHF3.02. Over the last year, Addex Therapeutics shares have traded in a share price range of CHF 3.02 to CHF 3.02.

Addex Therapeutics currently has 184,354,000 shares outstanding. The market capitalization of Addex Therapeutics is CHF556.75 million. Addex Therapeutics has a price to earnings ratio (PE ratio) of -52.71.

Addex to Present at the 2025 Swiss Equities Baader Conference

Addex to Present at the 2025 Swiss Equities Baader Conference Geneva, Switzerland, January 8, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on...

Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Addex Reports Third Quarter 2024 Financial Results and Provides Corporate Update Indivior selected GABA B PAM drug candidate for development in substance use disorders (SUD) and starts IND...

Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024

Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024 Nine-month Results Remain On Track for Net Profit Ad Hoc Announcement Pursuant to Art. 53 LR Geneva...

Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update

Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update Launched Neurosterix with Perceptive Advisors to accelerate the development of M4PAM...

Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit

Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, September 19, 2024 - Addex...

Addex to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Addex to Participate in the H.C. Wainwright 26th Annual Global Investment Conference Geneva, Switzerland, September 4, 2024 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage...

Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Collaboration

Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Collaboration Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, August 27, 2024...

Addex’s Partner Discontinues ADX71149 development in Epilepsy

Addex’s Partner Discontinues ADX71149 development in Epilepsy Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 22, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a...

Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS)

Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS) Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland...

Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)

Addex To Present at the Thirteenth London International Cough Symposium (13th LICS) Geneva, Switzerland, July 12, 2024 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage...

Period	Open	High	Low	Avg. Daily Vol	VWAP
1	3.02	3.02	3.02	0	0	DE
4	3.02	3.02	3.02	5	3.02	DE
12	3.02	3.02	3.02	605	3.02	DE
26	3.02	3.02	3.02	741	3.02	DE
52	3.02	3.02	3.02	922	3.02	DE
156	3.02	3.02	3.02	791	3.02	DE
260	3.02	3.02	3.02	761	3.02	DE

0QNV - Frequently Asked Questions (FAQ)

What is the current Addex Therapeutics share price?

The current share price of Addex Therapeutics is CHF 3.02

How many Addex Therapeutics shares are in issue?

Addex Therapeutics has 184,354,000 shares in issue

What is the market cap of Addex Therapeutics?

The market capitalisation of Addex Therapeutics is CHF 556.75M

What is the 1 year trading range for Addex Therapeutics share price?

Addex Therapeutics has traded in the range of CHF 3.02 to CHF 3.02 during the past year

What is the PE ratio of Addex Therapeutics?

The price to earnings ratio of Addex Therapeutics is -52.71

What is the cash to sales ratio of Addex Therapeutics?

The cash to sales ratio of Addex Therapeutics is 347.13

What is the reporting currency for Addex Therapeutics?

Addex Therapeutics reports financial results in CHF

What is the latest annual turnover for Addex Therapeutics?

The latest annual turnover of Addex Therapeutics is CHF 1.61M

What is the latest annual profit for Addex Therapeutics?

The latest annual profit of Addex Therapeutics is CHF -10.56M

What is the registered address of Addex Therapeutics?

The registered address for Addex Therapeutics is 12 CHEMIN DES AULX, GENEVA, 1228

What is the Addex Therapeutics website address?

The website address for Addex Therapeutics is www.addextherapeutics.com

Which industry sector does Addex Therapeutics operate in?

Addex Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AIQAiq Limited	4.00p (33.33%)	37.88k
INSPInspirit Energy Holdings Plc	0.0036p (28.57%)	1.43B
ALKAlkemy Capital Investments Plc	175.00p (27.27%)	176.27k
KNBKanabo Group Plc	1.00p (25.00%)	461.04k
TCFTheracryf Plc	1.125p (25.00%)	6.72M
MET1Metals One Plc	0.275p (-35.29%)	16.2M
PPSProton Motor Power Systems Plc	0.175p (-22.22%)	848.7k
SYMESupply@me Capital Plc	0.0025p (-19.35%)	372.49M
CGNRConroy Gold & Natural Resources Plc	2.15p (-18.87%)	739.53k
ONCOncimmune Holdings Plc	10.40p (-16.47%)	1.19M
INSPInspirit Energy Holdings Plc	0.0036p (28.57%)	1.43B
NTVONativo Resources Plc	0.0018p (-5.26%)	1.41B
MSMNMosman Oil And Gas Limited	0.041p (10.81%)	1.22B
TRPTower Resources Plc	0.0295p (0.00%)	691.76M
SYMESupply@me Capital Plc	0.0025p (-19.35%)	372.49M